REVIEW OF COST EFFECTIVENESS OF TRASTUZUMAB IN EARLY BREAST CANCER

被引：0
|
作者：
Van Rooijen, E. M. [1 ]
Krol, M. [2 ]
机构：
[1] Inst Med Technol Assessment iMTA, Rotterdam, Netherlands
[2] Erasmus Univ, Rotterdam, Netherlands
来源：
VALUE IN HEALTH | 2011年 / 14卷 / 07期
关键词：
D O I：
10.1016/j.jval.2011.08.1295
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A470 / A470
页数：1
相关论文
共 50 条
  • [1] COST-EFFECTIVENESS OF ADJUVANT TRASTUZUMAB FOR EARLY BREAST CANCER IN ASIA: A SYSTEMATIC REVIEW
    Rafar, Abdul N. R.
    Neoh, C. F.
    Othman, M. F.
    Hong, Y. H.
    [J]. VALUE IN HEALTH, 2018, 21 : S14 - S14
  • [2] Cost-Effectiveness of Trastuzumab as Adjuvant Therapy for Early Breast Cancer: A Systematic Review
    Chan, Agnes L. F.
    Leung, Henry W. C.
    Lu, Chin-Li
    Lin, Shun Jin
    [J]. ANNALS OF PHARMACOTHERAPY, 2009, 43 (02) : 296 - 303
  • [3] Cost-Effectiveness of Adjuvant Trastuzumab Therapy for Early Breast Cancer in Asia: A Systematic Review
    Rafar, Noor Razilah Abdul
    Hong, Yet Hoi
    Wu, David Bin-Chia
    Othman, Muhamad Faiz
    Neoh, Chin Fen
    [J]. VALUE IN HEALTH REGIONAL ISSUES, 2019, 18 : 151 - 158
  • [4] The cost-effectiveness issue of adjuvant trastuzumab in early breast cancer
    Norum, Jan
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2006, 7 (12) : 1617 - 1625
  • [5] Cost-effectiveness analysis of trastuzumab for early breast cancer in Brazil
    Botelho, Carlos Henrique
    Estevez-Diz, Maria Del Pilar
    Campolina, Alessandro Goncalves
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2022, 22 (01) : 63 - 72
  • [6] Cost effectiveness of trastuzumab in the adjuvant treatment of early breast cancer - A lifetime model
    Millar, J. Alasdair
    Millward, Michael J.
    [J]. PHARMACOECONOMICS, 2007, 25 (05) : 429 - 442
  • [7] Cost-effectiveness analysis of adjuvant therapy with trastuzumab for early breast cancer
    Wardley, Andrew M.
    Cameron, David A.
    Bell, Richard
    Erny, Samuel
    Cohen, Carole
    Geary, Una
    Walzer, Stefan
    Gyldmark, Marlene
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 95 - 96
  • [8] Trastuzumab in early stage breast cancer: A cost-effectiveness analysis for Belgium
    Neyt, Mattias
    Huybrechts, Michel
    Hulstaert, Frank
    Vrijens, France
    Ramaekers, Dirk
    [J]. HEALTH POLICY, 2008, 87 (02) : 146 - 159
  • [9] TRASTUZUMAB IN METASTATIC BREAST CANCER: A SYSTEMATIC REVIEW OF COST-EFFECTIVENESS ANALYSES
    Andrade, T. S. D.
    Mosegui, G. B. G.
    Miranda, E. S.
    Souza, T. F. G. D.
    Vianna, C. M. D. M.
    Silva, F. V. C.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A687 - A687
  • [10] Cost Effectiveness of Trastuzumab for Management of Breast Cancer in India
    Gupta, Nidhi
    Verma, Rohan Kumar
    Gupta, Sudeep
    Prinja, Shankar
    [J]. JCO GLOBAL ONCOLOGY, 2020, 6 : 205 - 216
12345